Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>
Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> have?
Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> published?
Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> has 2022 year in the ScholarIQ index.
What is the open-access status of Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>?
Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> has closed oa status in the ScholarIQ index.
What is the DOI of Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>?
The DOI for Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> is on the source record.
What is the PMID of Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>?
The PMID for Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> is on the source record.
What is the OpenAlex record for Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>?
The OpenAlex for Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp> is on the source record.